WATSON 453 (Guanfacine 2 mg)
Pill imprint WATSON 453 has been identified as Guanfacine hydrochloride 2 mg.
Guanfacine is used in the treatment of adhd; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 453 (Guanfacine 2 mg)
- Imprint:
-
WATSON 453
- Strength:
- 2 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0453
- Inactive Ingredients:
- lactose anhydrous
D&C Yellow No. 10
FD&C Red No. 40
povidone
stearic acid
microcrystalline cellulose
aluminum oxide
More resources
Guanfacine hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

